On Invalid Date, Edgewise Therapeutics (NASDAQ: EWTX) reported Q4 2023 earnings per share (EPS) of -$0.47, up 56.67% year over year. Total Edgewise Therapeutics earnings for the quarter were -$30.14 million. In the same quarter last year, Edgewise Therapeutics's earnings per share (EPS) was -$0.30.
As of Q1 2024, Edgewise Therapeutics's earnings has grown year over year. Edgewise Therapeutics's earnings in the past year totalled -$100.16 million.
What is EWTX's earnings date?
Edgewise Therapeutics's earnings date is Invalid Date. Add EWTX to your watchlist to be reminded of EWTX's next earnings announcement.
What was EWTX's revenue last quarter?
On Invalid Date, Edgewise Therapeutics (NASDAQ: EWTX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Edgewise Therapeutics's revenue was $0.00.
What was EWTX's revenue growth in the past year?
As of Q1 2024, Edgewise Therapeutics's revenue has grown null year over year. Edgewise Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.